Deloitte Names Doug Beaudoin Leader of the US Life Sciences and Health Care Industry and Appoints Stephen Burrill to Lead the Health Care Sector
NEW YORK, Nov. 5, 2018
NEW YORK, Nov. 5, 2018 /PRNewswire/ -- Deloitte today announced the appointments of Doug Beaudoin to lead its life sciences and health care (LSHC) practice in the United States and Stephen Burrill to lead its health care sector.
Working in close collaboration, Beaudoin, Burrill and life sciences sector leader Greg Reh will lead the overall strategic direction of the practice and implement go-to-market strategies for Deloitte's key businesses including audit, consulting, tax and advisory services. The LSHC practice comprises over 7,000 practitioners, serving nearly all of the industry's Fortune 500 companies. Beaudoin succeeds Bill Copeland who will retire from the organization next summer after more than 36 years. Burrill is the first leader of the newly expanded health care sector that integrates the health plan and health care provider practices.
"With their client-first mindset and experience delivering the breadth and depth of Deloitte to solve complex business challenges, Doug and Steve are ideally suited to lead our LSHC industry and health care sector practices," said Seema Pajula, U.S. industries and insights leader, Deloitte LLP. "We are excited about the future of LSHC, and thank Bill for his outstanding leadership as he enters the next chapter of his life."
Beaudoin will also continue to serve as Deloitte's global and U.S. LSHC consulting leader. With nearly 30 years of experience, he has exceptional depth in the life sciences and health care space, serving both commercial and government organizations.
"Exponential change is accelerating the pace of disruption in life sciences and health care. I look forward to leading our practice of dedicated professionals who are deeply committed to helping our clients navigate this new future of health," said Beaudoin.
Burrill has more than 35 years of experience serving clients across the health care spectrum and has led large, transformational projects involving acute care hospitals, ambulatory operations, clinics, and physician practices. Previously, he led Deloitte's health care providers practice.
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including 85 percent of the Fortune 500 and more than 6,000 private and middle market companies. Our people work across more than 20 industry sectors to deliver measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to make their most challenging business decisions with confidence, and help lead the way toward a stronger economy and a healthy society.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.
View original content to download multimedia:http://www.prnewswire.com/news-releases/deloitte-names-doug-beaudoin-leader-of-the-us-life-sciences-and-health-care-industry-and-appoints-stephen-burrill-to-lead-the-health-care-sector-300743734.html